Author: Clemons Traci E.
Publisher: Informa Healthcare
ISSN: 0928-6586
Source: Ophthalmic Epidemiology, Vol.20, Iss.2, 2013-04, pp. : 109-113
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Clemons Traci E. Gillies Marc C. Chew Emily Y. Bird Alan C. Peto Tunde Figueroa Maria J. Harrington Molly W.
Ophthalmic Epidemiology, Vol. 17, Iss. 1, 2010-02 ,pp. :
How Prevalent is Macular Telangiectasia Type 2?
Ophthalmic Epidemiology, Vol. 19, Iss. 4, 2012-08 ,pp. :
Unusual Presentations of Type 2 Idiopathic Macular Telangiectasia
Ophthalmologica, Vol. 230, Iss. 3, 2013-08 ,pp. :
Intravitreal Bevacizumab for Type 2 Idiopathic Macular Telangiectasia
Ophthalmic Research, Vol. 49, Iss. 4, 2013-01 ,pp. :